A Novel Missense Mutation in AFG3L2 Associated with ... - Springer Link

3 downloads 0 Views 949KB Size Report
Nov 29, 2013 - Holger Hackstein & Ulrich Müller & Dagmar Nolte. Received: 9 October 2013 /Accepted: 15 November 2013 /Published online: 29 November ...
J Mol Neurosci (2014) 52:493–496 DOI 10.1007/s12031-013-0187-1

A Novel Missense Mutation in AFG3L2 Associated with Late Onset and Slow Progression of Spinocerebellar Ataxia Type 28 Anna Mareike Löbbe & Jun-Suk Kang & Rüdiger Hilker & Holger Hackstein & Ulrich Müller & Dagmar Nolte

Received: 9 October 2013 / Accepted: 15 November 2013 / Published online: 29 November 2013 # Springer Science+Business Media New York 2013

Abstract SCA28 is caused by mutations in the AFG3L2 gene. This gene encodes a subunit of the mitochondrial metalloprotease AFG3L2 (AFG3-like protein 2). Clinical features of SCA28 include slow to moderate progressive ataxia, dysarthria, and additional symptoms such as nystagmus, slow saccades, and increased deep tendon reflexes. Here, we report on a novel AFG3L2 mutation in a patient with slowly progressive ataxia and a positive family history. The nucleotide change results in the substitution of an evolutionarily highly conserved tyrosine by histidine (p.Y689H) in the M41 peptidase domain of AFG3L2. Keywords Spinocerebellar ataxia . SCA28 . AFG3L2 . Mitochondrial m-AAA protease

Introduction Autosomal dominant spinocerebellar ataxias (SCA) are a large heterogeneous group of neurological disorders characterized by gait and limb ataxia, dysarthria, and nystagmus in combination with other clinical signs and symptoms such as dystonia, chorea, neuropathy, and cognitive impairment. MRI typically reveals atrophy of the cerebellum. To date, 31 different SCA loci and 24 genes are known (Bird 2013). Among those, A. M. Löbbe : U. Müller : D. Nolte (*) Institut für Humangenetik, Justus-Liebig Universität Giessen, Schlangenzahl 14, 35392 Giessen, Germany e-mail: [email protected] J.C) in the index patient compared to a control. Corresponding amino acid sequence is given. c Structure of the AFG3L2 gene and composition of the deduced protein. Mutated codons are marked by asterisks. Known aa exchanges are given in black, and novel one in red. Domains are given in accordance to the Pfam database (http://pfam.sanger.ac.uk; Punta et al. 2012). MTS mitochondrial

targeting sequence; TM1 and TM2 transmembrane domains 1 and 2, respectively; FtsH filamentation temperature sensitive H proteolytic domain. d Amino acid sequence alignment of parts of the M41 domain in AFG3L2 orthologs. Protein identifier numbers are given on the right. Mutation at highly conserved tyrosine residue at position 689 is highlighted in red . Known affected aa are marked by dots . Nonconserved residues are given in green. G. Gorilla; P. Pongo; C. Canis; B. Bos; R. Rattus; M. Mus; G. Gallus; X. Xenopus; D. Drosophila; C. Caenorhabditis

Table 1 AFG3L2 mutations in SCA28 patients

dominant movement disorder. SCA loci 1–3, 6–8, 10, 12–14, 17, and 27 had been excluded previously.

Exon Base exchange

Amino acid exchange

Author

10 15 16 16 16 16 16 16 16 16 16 16 16

p.N432T p.T654I p.M666V p.M666R p.M666T p.G671R p.G671E p.S674L p.Y689H p.E691K p.A694E p.E700K p.R702Q

Di Bella et al. 2010 Cagnoli et al. 2010 Cagnoli et al. 2010 Cagnoli et al. 2010 Cagnoli et al. 2010 Cagnoli et al. 2010 Cagnoli et al. 2010 Di Bella et al. 2010 novel Cagnoli et al. 2010 Di Bella et al. 2010 Edener et al. 2010 Di Bella et al. 2010

c.1295A>C c.1961C>T c.1996A>G c.1997T>G c.1997T>C c.2011G>A c.2012G>A c.2021_2022CC>TA c.2065T>C c.2071G>A c.2081C>A c.2098G>A c.2105G>A

Materials and Methods Genetic Analysis Twenty eight unrelated clinically proven SCA patients of German origin were studied. All had a positive family history consistent with autosomal dominant inheritance. MRI had revealed cerebellar atrophy in all cases. Repeat expansions in SCA1–3, 6–8, 10, 12, and 17 and point mutations in SCA13 (KCN3), SCA14 (PRKCG), and SCA27 (FGF14) had been previously excluded. All 17 exons and flanking intronic boundaries of the AFG3L2 gene (ENSG00000141385) were amplified by PCR and subsequently sequenced using the BigDye

J Mol Neurosci (2014) 52:493–496

Terminator Kit v2 (Applied Biosystems) according to the supplier's instructions. SeqScape v2.5 software (Applied Biosystems) was used for data analysis. Blood samples from the 28 ataxia patients had been submitted to our laboratory by neurologists in accordance with German law for genetic testing.

Case Report The patient came to clinical attention at age 60 due to mild gait and limb ataxia and impaired postural stability in combination with moderate dysarthria and occasional dysphagia. He displayed mild dysdiadochokinesia, dysmetria, and moderate hyperreflexia. Babinski sign was negative. Slow saccades were noted. There was no obvious cognitive impairment. The patient's feet were highly arched, and he had pallanesthesia at the first metatarsophalangeal joints. The Scale for Assessment and Rating of Ataxia (SARA) score (Schmitz-Hübsch et al. 2006) was 14.5. By history, the patient first manifested gait disturbances at age 43. Gait anomalies progressed slowly. During the last years, he fell frequently. He could not climb the stairs without aid, and he was unable to ride a bicycle. Fine motor movements were impaired. His condition worsened through fatigue and agitation. He reported occasional mild dysphagia. Family history revealed a similar movement disorder in his deceased father and in his paternal grandmother (Fig. 1a).

Results and Discussion S e q u e n c i n g o f th e p a t i e n t ' s A F G 3 L 2 t r a n s c r i p t (ENST00000269143) revealed a C to T transition in exon 16 at nucleotide position 2065 (c.2065T>C, cDNA.2297T>C, g.39864T>C; Fig. 1b). The nucleotide change results in the substitution of tyrosine by histidine (p.Y689H) in the M41 peptidase domain of AFG3L2 (Fig. 1c). Several reasons suggest that the nucleotide change is pathogenic: 1. The c.2065T>C change was not detected in the 1000 Genomes Database (http://www.1000genomes.org/), dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP/), and the Exome Variant Server (http://evs.gs.washington. edu/EVS/). 2. Additionally, c.2065T>C was not found in 240 healthy age-matched controls of German origin (480 chromosomes). 3. A computer-based analysis approach using the SIFT algorithm (http://blocks.fhcrc.org/sift/SIFT.html) (Kumar et al. 2009) and the MutationTaster tool (lhttp:// mutationtaster.org) predicts that the p.Y689H change is disease causing. 4. Tyrosine at position 689 of the M41 domain has been highly conserved during evolution. It is identical in all

495

vertebrates studied and in invertebrates such as Caenorhabditis elegans as well (Fig. 1d). Interestingly, of 52 amino acids of the carboxyterminal M41 domain, only 24 have been evolutionarily conserved (Fig. 1d) and seven of them were found mutated in SCA28 (Table 1) (Di Bella et al. 2010; Cagnoli et al. 2010; Edener et al. 2010). The mutation described here (p.Y689H) affects another highly conserved amino acid in this part of the M41 domain. To date, all mutations in SCA28 but one (c.1295A>C) in exon 10 (Di Bella et al. 2010) are located in exons 15 and 16 (Fig. 1c), respectively, that code for the M41 peptidase domain. The mutations interfere with homo- and heterooligomer formation of AFG3L2 (Cagnoli et al. 2010). Impairment of formation of the AFG3L2 oligomer complex affects mitochondrial protein synthesis and ribosome assembly and is the likely molecular pathogenic mechanism in SCA28 (Almajan et al. 2012). The AFG3L2 mutation was identified in one of 28 patients in whom autosomal dominant SCAs caused by repeat expansions had been excluded. This suggests a prevalence of 3.6 % among this group of ataxia patients in Germany. This is comparable to a reported prevalence of 3.0 % in Caucasian similarly preselected patients (Cagnoli et al. 2010). Age at onset varies widely in SCA28. While onset is during early adulthood in most cases (Cagnoli et al. 2006, 2010), childhood onset has been described in some (Edener et al. 2010). In the four-generation family described by Edener, age of disease onset varied greatly. In contrast, disease onset was comparable in the patients of the three-generation family reported here. Furthermore, while tendon reflexes were increased only moderately in the present patient, they appear to be greatly increased in most SCA28 cases (Cagnoli et al. 2006, 2010; Edener et al. 2010). In conclusion, the findings reported support the importance of malfunction of the M41 domain of AFG3L2 in the pathogenesis of SCA28 and further document that phenotypic variability is moderate in this disorder. Acknowledgments We are indebted to Sylvia Stanek for the excellent technical assistance. Conflict of interest The authors declare to have no conflict of interest.

References Almajan ER, Richter R, Paeger L et al (2012) AFG3L2 supports mitochondrial protein synthesis and Purkinje cell survival. J Clin Invest 122:4048–4058 Banfi S, Bassi MT, Andolfi G et al (1999) Identification and characterization of AFG3L2, a novel paraplegin-related gene. Genomics 59: 51–58

496 Bird TD. Hereditary Ataxia Overview. (1998, updated 2013). In: Pagon RA, Adam MP, Bird TD et al. (eds) GeneReviews™ [Internet]. University of Washington, Seattle. http://www.ncbi.nlm.nih.gov/ books/NBK1138/ Brussino A, Brusco A, Dürr A (2011, updated 2013) Spinocerebellar Ataxia Type 28. In: Pagon RA, Adam MP, Bird TD, et al. (eds) GeneReviews™ [Internet]. University of Washington, Seattle. http://www.ncbi.nlm.nih.gov/books/NBK54582/ Cagnoli C, Mariotti C, Taroni F et al (2006) SCA28, a novel form of autosomal dominant cerebellar ataxia on chromosome 18p11.22q11.2. Brain 129:235–242 Cagnoli C, Stevanin G, Brussino A et al (2010) Missense Mutations in the AFG3L2 proteolytic domain account for 1.5 % of European autosomal dominant cerebellar ataxias. Hum Mutat 31:1117–1124 Casari G, Fusco D, Ciarmatori S et al (1998) Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93:973–983

J Mol Neurosci (2014) 52:493–496 Di Bella D, Lazarro F, Brusco A et al (2010) Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat Genet 42:313–321 Edener U, Woellner J, Hehr U et al (2010) Early onset and slow progression of SCA28, a rare dominant ataxia in a large four-generation family with a novel AFG3L2 mutation. Eur J Hum Genet 18:965–968 Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding nonsynonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073–1081 Mariotti C, Brusco A, Di Bella D et al (2008) Spinocerebellar ataxia type 28: a novel autosomal dominant ataxia characterized by slow progression and ophtahlmoparesis. Cerebellum 7:184–188 Punta M, Coggill PC, Eberhardt RY et al (2012) The Pfam protein families database. Nucleic Acids Res 40:D290–D301 Schmitz-Hübsch T, du Montcel ST, Baliko L et al (2006) Scale for the assessment and rating of ataxias: development of a new clinical scale. Neurology 66:1717–1720